Turning a new phage
- 7 September 2012
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 18 (9), 1318-1320
- https://doi.org/10.1038/nm0912-1318
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Antistaphylococcal activity of bacteriophage derived chimeric protein P128BMC Microbiology, 2012
- Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive GenesApplied and Environmental Microbiology, 2012
- A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus StrainsAntimicrobial Agents and Chemotherapy, 2011
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacyClinical Otolaryngology, 2009
- Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyProceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of a Broadly Active Phage Lytic Enzyme with Lethal Activity against Antibiotic-Resistant Enterococcus faecalis and Enterococcus faeciumJournal of Bacteriology, 2004
- A bacteriolytic agent that detects and kills Bacillus anthracisNature, 2002
- Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzymeProceedings of the National Academy of Sciences of the United States of America, 2001
- PURIFICATION AND PHYSICAL PROPERTIES OF GROUP C STREPTOCOCCAL PHAGE-ASSOCIATED LYSINThe Journal of Experimental Medicine, 1971